Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

BACKGROUND: The aim of this study was to elucidate the prognostic impact of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and aldehyde dehydrogenase-1 (ALDH1) in colorectal cancer. METHODS: A tissue microarray of 1420 primary colorectal cancers and 57 normal mucosa samples was immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugli, A, Iezzi, G, Hostettler, I, Muraro, M G, Mele, V, Tornillo, L, Carafa, V, Spagnoli, G, Terracciano, L, Zlobec, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920016/
https://www.ncbi.nlm.nih.gov/pubmed/20606680
http://dx.doi.org/10.1038/sj.bjc.6605762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920016/
https://www.ncbi.nlm.nih.gov/pubmed/20606680
http://dx.doi.org/10.1038/sj.bjc.6605762

Ejemplares similares